WallStreetZenWallStreetZen

NASDAQ: ATXI
Avenue Therapeutics Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

ATXI earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$10.4M
Current Profit Margin
0%

ATXI Return on Equity

Current Company
N/A
Current Industry
15.6%
Current Market
-9.5%

Be the first to know when ATXI announces earnings.

ATXI Return on Assets

Current Company
-239.2%
Current Industry
2.2%
ATXI is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ATXI Return on Capital Employed

Current Company
230.92%
Current Industry
17.7%
ATXI has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ATXI vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ATXI$0.00-$10.44M-$10.44MN/AN/A
IBIO$50.00k-$51.31M-$52.63M-32.88%N/A
INM$4.72M-$6.37M-$6.97M+234.46%N/A
NBY$14.64M-$13.46M-$15.73M-0.74%N/A
ALLR$0.00-$12.90M-$21.80MN/AN/A
View Top Biotech Stocks

Avenue Therapeutics Earnings & Revenue FAQ

What were ATXI's earnings last quarter?

On Invalid Date, Avenue Therapeutics (NASDAQ: ATXI) reported Q3 2023 earnings per share (EPS) of $0.06, up 113.33% year over year. Total Avenue Therapeutics earnings for the quarter were $526.00 thousand. In the same quarter last year, Avenue Therapeutics's earnings per share (EPS) was -$0.45.

If you're new to stock investing, here's how to buy Avenue Therapeutics stock.

What was ATXI's earnings growth in the past year?

As of Q4 2023, Avenue Therapeutics's earnings has grown year over year. Avenue Therapeutics's earnings in the past year totalled -$10.44 million.

What was ATXI's revenue last quarter?

On Invalid Date, Avenue Therapeutics (NASDAQ: ATXI) reported Q3 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Avenue Therapeutics's revenue was $0.00.

What was ATXI's revenue growth in the past year?

As of Q4 2023, Avenue Therapeutics's revenue has grown null year over year. Avenue Therapeutics's revenue in the past year totalled $0.00.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.